We are live on ! Find out more
CLB icon

Core Laboratories

346 hedge funds and large institutions have $6.61B invested in Core Laboratories in 2014 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 137 increasing their positions, 122 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more repeat investments, than reductions

Existing positions increased: 137 | Existing positions reduced: 122

2% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 42

0% more funds holding

Funds holding: 346346 (0)

0.51% less ownership

Funds ownership: 89.45%88.94% (-0.51%)

17% less capital invested

Capital invested by funds: $7.98B → $6.61B (-$1.37B)

27% less funds holding in top 10

Funds holding in top 10: 118 (-3)

45% less call options, than puts

Call options by funds: $29.5M | Put options by funds: $53.2M

Holders
346
Holders Change
Holders Change %
0%
% of All Funds
9.95%
Holding in Top 10
8
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-27.27%
% of All Funds
0.23%
New
43
Increased
137
Reduced
122
Closed
42
Calls
$29.5M
Puts
$53.2M
Net Calls
-$23.8M
Net Calls Change
+$4.89M
Name Holding Trade Value Shares
Change
Change in
Stake
Ameriprise
76
Ameriprise
Minnesota
$11.9M -$111K -622 -0.9%
TAM
77
Tocqueville Asset Management
New York
$11.2M +$249K +1,400 +2%
CHAM
78
Clear Harbor Asset Management
Connecticut
$11M +$26.5K +149 +0.2%
SIMG
79
Stephens Investment Management Group
Texas
$10.9M -$89K -500 -0.8%
Millennium Management
80
Millennium Management
New York
$10.9M +$11.6M +65,030 New
Dimensional Fund Advisors
81
Dimensional Fund Advisors
Texas
$10.7M +$4.22M +23,695 +59%
TCIM
82
TIAA CREF Investment Management
New York
$10.5M +$2.81M +15,791 +33%
Charles Schwab
83
Charles Schwab
California
$10.5M +$376K +2,111 +3%
ACH
84
ArrowMark Colorado Holdings
Colorado
$10.5M -$709K -3,984 -6%
CS
85
Credit Suisse
Switzerland
$10.1M -$3.9M -21,921 -27%
TG
86
TCW Group
California
$10.1M -$2.54M -14,271 -19%
Canada Life
87
Canada Life
Manitoba, Canada
$9.53M -$12M -67,242 -54%
AIM
88
Arcadia Investment Management
Michigan
$9.24M +$2.9M +16,297 +42%
Bank of America
89
Bank of America
North Carolina
$9.22M -$1.9M -10,691 -16%
SRC
90
Shufro Rose & Co
New York
$9.2M +$9.79M +55,051 New
U
91
UBS
Switzerland
$9.14M +$3.86M +21,712 +66%
JMPWA
92
JP Morgan Private Wealth Advisors
California
$9.1M +$7.81M +43,884 +415%
AAM
93
Aberdeen Asset Management
United Kingdom
$8.8M +$9.37M +52,675 New
LWCFA
94
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$8.73M -$95K -534 -1%
Barclays
95
Barclays
United Kingdom
$8.25M -$496K -2,789 -5%
FIM
96
Friedberg Investment Management
Texas
$7.92M +$53.4K +300 +0.6%
ACI
97
AMP Capital Investors
Australia
$7.73M +$4.75M +26,701 +134%
BJ
98
BlackRock Japan
Japan
$7.64M -$1.39M -7,832 -15%
BA
99
BlackRock Advisors
Delaware
$7.55M +$855K +4,808 +12%
APG Asset Management
100
APG Asset Management
Netherlands
$7.51M +$411K +2,313 +5%

CLB Hedge Fund Activity: Q2 2014 in Review

346 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q2 2014, worth a combined $6.61B — down 17% from $7.98B a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new CLB positions and 42 closed out — a net gain of 1 holder — while 137 added to existing stakes and 122 trimmed.

The largest buyer was Vontobel Asset Management, adding an estimated $147M. The largest seller was Carmignac Gestion, exiting entirely with an estimated $604M sold.

  • 346 institutional investors held Core Laboratories (CLB) as of Q2 2014, unchanged from Q1 2014.
  • Funds reported $6.61B of Core Laboratories stock for Q2 2014, down 17% quarter-over-quarter.
  • 43 funds opened new Core Laboratories positions in Q2 2014 and 42 closed out, a net change of +1 holder.
  • The largest Core Laboratories buyer in Q2 2014 was Vontobel Asset Management, an estimated $147M added.
  • The largest Core Laboratories seller in Q2 2014 was Carmignac Gestion, an estimated $604M sold.

Based on aggregated 13F filings for Q2 2014.